Compound Detail
CHEMBL5189621
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL5189621 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CVKBYFCJQSPBOI-UHFFFAOYSA-N |
2
Targets
2
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
305.4
MW (Da)
2.58
ALogP
4
HBA
1
HBD
72.5
PSA (Ų)
0.88
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 2 meas. best 6.24
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HCT-116 CHEMBL394 | IC50 | 6.24 | 6.24 | 580.0 | 1 |
| TCF4-CTNNB1 complex CHEMBL3885541 | IC50 | 6.23 | 6.23 | 583.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| HCT-116 | IC50 | = | 580.0 | nM | 6.24 | Anticancer activity against human HCT-116 cells assessed as reduction in cell vi... | 33445154 |
| TCF4-CTNNB1 complex | IC50 | = | 583.0 | nM | 6.23 | Inhibition of beta-Catenin (301 to 670 residues)/TCF4 protein-protein interactio... | 36183504 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35581674 | 10.1021/acs.jmedchem.2c00228 | Catenin beta-1 | 1 |
| 33445154 | 10.1016/j.ejmech.2020.113149 | HCT-116 | 1 |
| 36183504 | 10.1016/j.ejmech.2022.114789 | TCF4-CTNNB1 complex | 1 |
Data from ChEMBL 36 via Core Engine